---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-052405"
form_type: "8-K"
ticker: "ONMD"
cik: "0001849380"
company_name: "OneMedNet Corp"
filed_at: "2024-12-30T23:59:59+00:00"
generated_at: "2026-05-28T22:51:10.126269+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# OneMedNet regains Nasdaq compliance after filing overdue quarterly reports

## Summary
- Received Nasdaq notice confirming compliance with Listing Rule 5250(c)(1) after filing Q1-Q3 2024 Form 10-Qs.
- Appointed Bob Golden as interim CFO, hired Director of Business Development and VP of Marketing.
- Signed agreement with Bayer's AI Innovation Platform in early December.
- Raised ~$6.4M in private placements with Off the Chain Capital and Discovery Capital Management affiliate.
- Adopted Bitcoin on balance sheet treasury strategy.

## SEC filing metadata
- accession: 0001493152-24-052405
- form_type: 8-K
- ticker: ONMD
- cik: 0001849380
- company_name: OneMedNet Corp
- filed_at: 2024-12-30T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1849380/000149315224052405/0001493152-24-052405-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1849380/000149315224052405/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-052405
- JSON: https://secwatch.observer/filing/0001493152-24-052405.json
- Plain text: https://secwatch.observer/filing/0001493152-24-052405.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
